Key facts
- It has raised $660K; the latest was Early Stage VC ($200K) in Jun 2025.
- Notable investors include Heriot-Watt University, ICURe, Proven Connect, The Bayes Centre for Entrepreneurship.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Less Grey Imaging
- ·The full record, as it builds
Funding rounds
No funding rounds for Less Grey Imaging are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Less Grey Imaging
Provider of an image analysis tool for direct microvascular mapping intended to pinpoint prostate cancer. The company offers clinical contrast-enhanced ultrasound data and direct super-resolution images of the prostate, with an increase in resolution, enabling clinicians to identify diseased regions of interest and perform the clinical assessment and resulting decrease in patient death.
- Sector
- Healthcare
- HQ
- Edinburgh, United Kingdom
- Founded
- 2023
- Employees
- 5
- Website
- lessgreyimaging.com/
- Ownership
- Privately Held (backing)
Less Grey Imaging doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Less Grey Imaging shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Less Grey Imaging in its N-PORT filings yet. We sweep new filings monthly.